Renal cell carcinoma represents more than 90 % of all malignant kidney tumors.
International guidelines for follow-up examinations after surgery for kidney tumors are still incomplete. New challenges are arising because of growing use of nephron sparing surgery. According to well-known prognosticators risk-adapted follow-up strategies may be established that are stratified into 3 risk groups.
Written by:
Kories C, Ubrig B. Are you the author?
Klinik für Urologie Bochum, Zentrum für minimal-invasive und robotisch assistierte urologische Chirurgie, Augusta- Kranken-Anstalt gGmbH, Bochum, Germany.
Reference: Aktuelle Urol. 2013 May;44(3):211-20; quiz 221-2.
doi: 10.1055/s-0032-1328599
PubMed Abstract
PMID: 23712279
Article in German.
UroToday.com Renal Cancer Section
